GADDUCCI, ANGIOLO Statistiche
GADDUCCI, ANGIOLO
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
'Bat-like' choroid plexus and other sonographic features in trisomy 22 at the first trimester of pregnancy.
2013-01-01 Luchi, C.; Monacci, F.; Schifano, M.; Gadducci, Angiolo
. Anticomplement and heparin-like activities in human placentas from term deliveries in women affected by diabetes mellitus (DM) and in woman affected by gestosis (EPH)
1982-01-01 Moggi, G; Brunori De Luca, I; Teti, G; Chisci, R; Gadducci, Angiolo; Tellini, N; Bianchini, P; Fioretti, P.
. Il CA125 ed altri indicatori umorali nella diagnostica delle neoplasie epiteliali maligne dell'ovaio
1984-01-01 Ferdeghini, M; Gadducci, Angiolo; Prato, B; Nicolini, A; Bartolini, T; Scatena, P; Facchini, V; Bianchi, R; Fioretti, P.
. The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma
1989-01-01 Gadducci, Angiolo; Ferdeghini, M; Bartolini, T; Mariani, G; Bianchi, R; Fioretti, P.
.Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.
2016-01-01 Gadducci, Angiolo; Cosio, S; Fanucchi, A; Tana, Roberta; Manacorda, Simona; Pistolesi, Sabina; Strigini, Fl
A comparison of several tumor markers in the diagnosis, monitoring and follow-up of patients with epithelial ovarian cancer
1989-01-01 Gadducci, Angiolo; Ferdeghini, M; Bianchi, R; Fioretti, P.
A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
2019-01-01 Tognarelli, Alessio; Faggioni, Lorenzo; Manassero, Francesca; Gadducci, Angiolo; Selli, Cesare
A combination of CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI in the monitoring of ovarian carcinoma
1989-01-01 Gadducci, Angiolo; Ferdeghini, M; Facchini, V; Ceccarini, T; Prontera, C; Bianchi, R; Fioretti, P.
A comparative evaluation of the ability of serum CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma
1990-01-01 Gadducci, Angiolo; Ferdeghini, M; Ceccarini, T; Prontera, C; Facchini, V; Bianchi, R; Fioretti, P.
A comparison of the usefullness of serum measurements of CA125, CA50 and TATI in patients with malignant and benign gynecological pathology
1990-01-01 Gadducci, Angiolo; Ferdeghini, M; Facchini, V; Ceccarini, T; Prontera, C; Bianchi, R; Fioretti, P.
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma.
1990-01-01 Gadducci, Angiolo; Ferdeghini, M; Prontera, C; Giordano, P; Cristofani, R; Bianchi, R; Fioretti, P.
A narrative review of pregnancy after malignancies in young women that don't originate in the female genital organs or in the breast
2021-01-01 Girardelli, S.; Mangili, G.; Cosio, S.; Rabaiotti, E.; Fanucchi, A.; Valsecchi, L.; Candiani, M.; Gadducci, A.
A phase II combination study of bortezomib with pegylated-liposomal doxorubicin in patients with ovarian cancer failing platinum containing regimens
2008-01-01 Scambia, G; Parma, G; Del Conte, G; Hess, D; Gadducci, Angiolo; Katzaros, D; Sessa, C; Trudel, Gc; Coceani, N; Colombo, N.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
2018-01-01 Gadducci, Angiolo; F, Grosso; G, Scambia; F, Raspagliesi; N, Colombo; G, Grignani; P, Casali; R, Sanfilippo; A, Buonadonna; A, Santoro; M, Bruzzone; G, Artioli; D, Lorusso; E, Biagioli; R, Fossati; F, Galli; E, Negri; E, Rulli; V, Torri; M, D'Incalci
A randomized trial of the North West Oncology Group (GONO) comparing intraperitoneal (ip) versus intravenous (iv) cisplatin (CDDP) in combimation with epidoxorubicin (epidox) and cyclophosphamide (CTX) in advanced ovarian carcinoma patients with residual disease <2cm after initial laparotomy
1997-01-01 Gadducci, Angiolo; Brunetti, I; Fanucchi, A; Bruzzone, M; Carnino, F; Gagetti, O; Mammoliti, N; Ragni, N; Conte, Pf; Genazzani, Ar
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit?
2016-01-01 Laliscia, Concetta; Delishaj, Durim; Fabrini, Maria Grazia; Gonnelli, Alessandra; Morganti, Riccardo; Perrone, Franco; Tana, Roberta; Paiar, Fabiola; Gadducci, Angiolo
Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables
2019-01-01 Gadducci, A.; Guerrieri, M. E.; Cosio, S.
Adenoid Cystic Carcinoma of Bartholin's Gland: What Is the Best Approach?
2020-01-01 Barcellini, A.; Gadducci, A.; Laliscia, C.; Imparato, S.; Vitolo, V.; Preda, L.; Valvo, F.
Adenosarcomi dell' utero : analisi di 11 casi. Uno studio multicentrico CTF
1995-01-01 Bazzurrini, L; Sartori, E; Gadducci, Angiolo; Landoni, F; Maggino, T; Zola, P; La Face, B.
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study
2016-01-01 Mangili, G; Ottolina, J; Cormio, G; Loizzi, V; De Iaco, P; Pellegrini, Da; Candiani, M; Giorda, G; Scarfone, G; Cecere, Sc; Frigerio, Lorenzo; Gadducci, Angiolo; Marchetti, C; Ferrandina, G. 1. 2.